Dendritic cells: a journey from laboratory to clinic.
Dendritic cell-based vaccines have been rapidly transferred from the laboratory to the clinic. As the full potential of these cells has not yet been entirely exploited, many strategies could improve the immunogenicity of these vaccines.
Principais autores: | Cerundolo, V, Hermans, I, Salio, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2004
|
Registros relacionados
-
CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
por: Salio, M, et al.
Publicado em: (2004) -
Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells.
por: Salio, M, et al.
Publicado em: (2000) -
Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
por: Hermans, I, et al.
Publicado em: (2007) -
Lack of dendritic cell maturation by the plant toxin ricin.
por: Smith, D, et al.
Publicado em: (2004) -
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
por: Hermans, I, et al.
Publicado em: (2003)